# Major Recall Alert: CEFAZOLIN FOR INJECTION USP Recalled Due to Underfilled Vials
When it comes to healthcare, accuracy is paramount. A recent recall involving **CEFAZOLIN FOR INJECTION USP** highlights the importance of vigilance with pharmaceutical products. Health Canada has issued an urgent recall for this product due to vials in the affected lot being **underfilled**, causing potential risks to patient safety. Here’s what you need to know and how you can stay informed.
## Why This Recall is Important
CEFAZOLIN FOR INJECTION USP is a widely used antibiotic, typically administered in hospitals and healthcare facilities to treat various severe bacterial infections. An **underfilled vial** poses the risk of:
- **Insufficient treatment**: Patients may not receive a full dose, potentially leading to treatment failure or the worsening of life-threatening infections.
- **Inconsistent dosing**: This could contribute to incomplete clinical outcomes and promote antibiotic resistance, a major public health concern.
When dealing with medications that save lives, even minor deviations, like underfilled vials, could have serious repercussions.
## Details of the Recall
Here are the official details Health Canada has provided about the recall:
- **Product Name**: CEFAZOLIN FOR INJECTION USP
- **Reason for Recall**: Vials in the affected lot may be **underfilled**.
- **Date Recall Was Announced**: [Date Not Specified]
- **Who Is Affected**: Healthcare professionals, medical facilities, and patients receiving CEFAZOLIN FOR INJECTION USP from the affected lot.
For an official update and more information, visit Health Canada's recall page: [Health Canada’s Recalls and Alerts Portal](https://recalls-rappels.canada.ca/en/alert-recall/cefazolin-injection-vials-may-be-underfilled-affected-lot).
## What You Should Do
If you’re a healthcare provider or a medical facility that stocks CEFAZOLIN FOR INJECTION USP, here’s what you need to do to ensure safety:
- **Immediate Action for Inventory**: Check your inventory for any vials of CEFAZOLIN FOR INJECTION USP that could belong to the affected lot.
- **Discontinue and Isolate**: Stop using the affected lot immediately and set it aside to prevent accidental administration.
- **Contact the Supplier**: Notify the supplier or manufacturer for further instructions on returning or replacing the product.
- **Monitor Patients**: Patients who may have received incomplete doses should be closely monitored for any signs of infection relapse or complications.
If you’re a patient, consult your healthcare provider if you have any concerns about recent treatments involving this medication.
## Stay Safe – Get Instant Recall Alerts
To protect yourself, your patients, or loved ones from health risks associated with product recalls like this one, staying informed is key. With real-time recall alerts, you can act quickly and prevent potential harm.
**Download our app today** to:
- Receive instant notifications about recalls in Canada.
- Get updates on pharmaceuticals, food products, and more.
- Ensure the safety of your household and community.
[**Download Now**]
It’s essential for healthcare professionals and patients to remain proactive when it comes to recalls. By taking swift action and staying updated, we can minimize potential risks and ensure proper care.
For official details on this recall of **CEFAZOLIN FOR INJECTION USP**, visit [Health Canada's Recall Announcement](https://recalls-rappels.canada.ca/en/alert-recall/cefazolin-injection-vials-may-be-underfilled-affected-lot).
Stay vigilant. Stay informed. **Your health and safety are always a priority!**